Wells Fargo Says Buy Micro-Cap Drugmaker Ahead Of Cancer Immunotherapy Meeting
October 12, 2017 at 13:31 PM EDT
Shares of Infinity Pharmaceuticals are on the rise after Wells Fargo analyst Jim Birchenough upgraded the stock to a buy-equivalent rating.
